Monkeypox - Symptoms, Causes, Treatment & Prevention

📅 Updated: April 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Monkeypox – Comprehensive Medical Guide

Monkeypox – Comprehensive Medical Guide

Overview

Monkeypox is a viral disease caused by the Monkeypox virus (MPXV), a member of the Orthopoxvirus genus that also includes smallpox (Variola) and vaccinia (the vaccine strain). The illness is typically self‑limited but can be severe, especially in people with weakened immune systems.

Who it affects: Historically, most cases occurred in Central and West African countries where the virus circulates in wildlife. Since 2022, larger outbreaks have been documented in Europe, the Americas, and Asia, largely among men who have sex with men (MSM), but anyone with close contact to an infected person or animal can become infected.

Prevalence (2023 data): The World Health Organization (WHO) reported ≈ 87,000 confirmed cases worldwide from January 2022 to December 2023, with the United States, Spain, Brazil, and the United Kingdom accounting for > 70 % of cases. In the United States, the CDC recorded ~31,000 cases and ~50 deaths as of mid‑2024.[CDC, 2024]

Symptoms

The incubation period ranges from 5 to 21 days (average ≈ 7 days). Illness usually follows a two‑phase pattern: prodrome followed by a characteristic rash.

Prodromal (early) symptoms

  • Fever – 38–40 °C, often the first sign.
  • Headache – throbbing or pressure‑type.
  • Muscle aches (myalgia) and back pain.
  • Lymphadenopathy – swelling of lymph nodes, especially in the neck, groin, or armpits (distinguishes monkeypox from smallpox).
  • Fatigue and malaise.
  • Chills and sometimes rigors.

Rash (cutaneous) phase

  • Begins 1–3 days after fever onset, often on the face then spreads to extremities, palms, soles, and genital area.
  • Lesions evolve through 5 stages:
    1. Macules (flat, pink)
    2. Papules (raised)
    3. Vesicles (filled with clear fluid)
    4. Pustules (filled with pus) – most infectious stage
    5. Scabs (dry, crusted) – fall off after 2–4 weeks
  • Lesions are deep‑seated, well‑circumscribed and may be painful or itchy.
  • Number of lesions: can range from a few (<10) to > 100 (severe cases).
  • Oral mucosa, conjunctiva, and genital mucosa may also develop lesions.

Other possible manifestations

  • Respiratory symptoms (cough, sore throat)
  • Gastrointestinal upset (nausea, vomiting, diarrhoea)
  • Eye involvement – conjunctivitis or keratitis, which can threaten vision.
  • Neurologic signs – headache, confusion, or rare encephalitis.

Causes and Risk Factors

What causes monkeypox?

The disease is caused by infection with the Monkeypox virus, an enveloped double‑stranded DNA virus.

  • Zoonotic transmission: Contact with infected animals (primates, rodents, squirrels) through bites, scratches, or handling of meat.
  • Human‑to‑human transmission: Direct contact with skin lesions, bodily fluids, respiratory droplets (usually during prolonged close contact), or contaminated materials (clothing, bedding).
  • Sexual transmission: While not classified as a classic STI, many 2022‑2023 cases were linked to intimate sexual contact, likely due to skin‑to‑skin exposure.

Who is at higher risk?

  • People living in or traveling to endemic regions (e.g., Democratic Republic of the Congo, Nigeria).
  • Men who have sex with men (MSM) having multiple partners or attending large gatherings.
  • Individuals with weakened immune systems (e.g., untreated HIV, chemotherapy, organ transplants).
  • Healthcare workers or laboratory staff handling orthopoxviruses without appropriate protective equipment.
  • Persons with close, unprotected contact with an infected animal or its body fluids.

Diagnosis

Clinical assessment

Clinicians first evaluate a patient’s travel history, exposure risk, and the presence of the characteristic rash with lymphadenopathy.

Laboratory tests

  • Polymerase chain reaction (PCR) – The gold‑standard test performed on swabs from lesion crusts, vesicle fluid, or skin biopsies. Results are available within 24–48 hours in most reference labs.
  • Viral culture – Rarely used due to biosafety concerns (BSL‑3 required).
  • Serology (IgM/IgG) – Helpful later in disease or for epidemiologic studies, not for acute diagnosis.
  • Electron microscopy – Can visualize characteristic poxvirus particles but available only in specialized centers.

Specimen handling

Lesion material should be placed in a dry sterile tube; avoid transport in liquid media that may dilute the viral load. Labs must follow CDC/WHO biosafety guidelines.

Treatment Options

Most infections are mild and resolve without specific therapy, but antiviral agents are available for severe disease or high‑risk patients.

Antiviral medications

  • Tecovirimat (TPOXX) – FDA‑approved for smallpox; shown to reduce viral load and symptom duration in monkeypox. Oral 600 mg twice daily for 14 days (dose adjustment for renal/hepatic impairment).
  • Cidofovir and its lipid‑conjugated form Brincidofovir (CMX001) – Used under compassionate‑use protocols; may cause nephrotoxicity (cidofovir) or gastrointestinal side effects (brincidofovir).

Supportive care

  • Hydration and nutritional support.
  • Pain control (acetaminophen, ibuprofen). Use opioids only for severe pain.
  • Topical agents for itching (calamine lotion, antihistamine creams).
  • Eye care – lubricating eye drops and ophthalmology referral if conjunctivitis develops.

Isolation and infection‑control measures

  • Patients should remain in a single room with a private bathroom until all lesions have crusted, fallen off, and fresh skin has formed (usually 2–4 weeks).
  • Standard, contact, and droplet precautions for healthcare workers (gown, gloves, N95 respirator or surgical mask, eye protection).

Lifestyle & home‑care adjustments

  • Avoid scratching lesions to prevent secondary bacterial infection.
  • Use separate towels, bedding, and utensils for the infected person.
  • Maintain good hand hygiene (soap & water >20 seconds or alcohol‑based sanitizer).

Living with Monkeypox

Daily management tips

  • Monitor lesions daily; note any increase in size, pus, or spreading.
  • Record temperature twice daily; persistent fever > 38.5 °C warrants medical review.
  • Hydration – Aim for ≥ 2 L water/day unless contraindicated.
  • Nutrition – High‑protein foods aid skin healing.
  • Rest – Adequate sleep (7–9 hours) supports immune function.
  • Psychological support – Isolation can be stressful; consider virtual counseling or peer‑support groups.
  • Vaccination of contacts – The newer Jynnev® (MVA‑BN) vaccine can be offered as post‑exposure prophylaxis within 4 days of exposure.

When to contact your healthcare provider

  • New fever or worsening fever after initial improvement.
  • Rapid spread of lesions or development of large ulcerated lesions.
  • Signs of secondary bacterial infection (increased redness, warmth, pus, foul odor).
  • Vision changes, eye pain, or discharge.
  • Neurologic symptoms such as confusion, severe headache, or seizures.

Prevention

  • Vaccination:
    • Jynnev® (Modified Vaccinia Ankara‑BN) – approved for monkeypox prevention; given as a two‑dose series 4 weeks apart.
    • Smallpox vaccine (ACAM2000) provides cross‑protection; used in select high‑risk groups.
  • Avoid contact with wild animals that may carry the virus; wear gloves when handling carcasses or raw meat.
  • Practice safe sex:
    • Use condoms consistently.
    • Discuss recent rashes or lesions with partners.
  • Hand hygiene after touching potentially contaminated surfaces.
  • Environmental cleaning: Disinfect surfaces with EPA‑registered agents effective against orthopoxviruses (e.g., 0.1 % sodium hypochlorite, 70 % ethanol).
  • Travel precautions: Review CDC travel notices before visiting endemic regions; consider pre‑travel vaccination.

Complications

While most patients recover, complications can arise, particularly in immunocompromised hosts.

  • Secondary bacterial infection of skin lesions – may lead to cellulitis or sepsis.
  • Pneumonia – viral or bacterial, presenting with cough, dyspnea, and infiltrates on chest X‑ray.
  • Encephalitis – rare but serious; presents with altered mental status, seizures.
  • Ocular involvement – conjunctivitis, keratitis, or corneal scarring causing vision loss.
  • Pregnancy complications – fetal loss or congenital infection (similar to variola). Pregnant women should receive prompt antiviral therapy and be monitored closely.
  • Scarring and post‑inflammatory hyperpigmentation – may be cosmetically distressing.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you develop any of the following:
  • Severe or worsening shortness of breath.
  • Chest pain or pressure that does not improve with rest.
  • Sudden confusion, seizures, or loss of consciousness.
  • High fever (≥ 40 °C / 104 °F) that does not respond to antipyretics.
  • Rapidly spreading skin lesions with extensive redness, swelling, or foul odor (signs of necrotizing infection).
  • Severe eye pain, vision loss, or discharge.
  • Bleeding from lesions or uncontrolled hemorrhage.

Prompt medical attention can prevent life‑threatening complications.

References

```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References